{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:10:35Z","timestamp":1763766635871,"version":"3.45.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,14]]},"abstract":"<jats:p>Emerging evidence from recent pathological investigations has demonstrated that chronic inflammation plays a pivotal role in the pathogenesis of intestinal diseases, including inflammatory bowel disease (IBD), ulcerative colitis (UC), Crohn disease (CD), colorectal adenocarcinoma (CAC), and colorectal cancer (CRC). However, the precise regulatory mechanisms of inflammatory cytokines remain incompletely elucidated, and the causal relationships between inflammatory responses and intestinal diseases require further validation. This study employed a two-sample Mendelian randomization (MR) approach to comprehensively evaluate potential causal associations between 91 circulating inflammatory factors and these 5 intestinal diseases. MR analysis revealed a significant causal relationship between the levels of inflammatory factors C-C motif chemokine 19 and CD40L receptor and the risk of IBD. Furthermore, CD, UC and CRC respectively showed potential causal relationships with inflammatory factors C-C motif chemokine 20, Programmed cell death 1 ligand 1 and interleukin-5. No inflammatory factor showed a causal relationship with CAC. Reverse MR Analysis indicated that the progression of CRC could significantly regulate the expression level of the inflammatory factor Macrophage colony-stimulating factor 1. Unlike most previous studies that merely focused on the association between a certain inflammatory factor and intestinal diseases, this study was the first to systematically identify the relationships between 91 inflammatory factors and intestinal diseases based on the MR method. These results not only deepen our understanding of the inflammatory regulatory mechanism of intestinal diseases, but also provide a theoretical basis for the development of future clinical early diagnosis and targeted treatment strategies.<\/jats:p>","DOI":"10.1097\/md.0000000000045735","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:02:15Z","timestamp":1763154135000},"page":"e45735","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causality relationship between 91 inflammatory factors and 5 intestinal diseases: A two-sample bidirectional Mendelian randomized study"],"prefix":"10.1097","volume":"104","author":[{"given":"Xiaokui","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Fourth People\u2019s Hospital of Chengdu, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4467-785X","authenticated-orcid":false,"given":"Tong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Fourth People\u2019s Hospital of Chengdu, The Clinical Hospital of Chengdu Brain Science Institute, University of Electronic Science and Technology of China, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251121","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis.","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"R2-20251121","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.gastro.2024.10.050","article-title":"Impact of parental crohn\u2019s disease on offspring\u2019s gut health and disease vulnerability.","volume":"169","author":"Li","year":"2025","journal-title":"Gastroenterology"},{"key":"R3-20251121","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41392-024-02063-0","article-title":"Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer.","volume":"9","author":"Qiu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R4-20251121","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s13402-011-0027-7","article-title":"Tumor necrosis factor-\u03b1 is associated with positive lymph node status in patients with recurrence of colorectal cancer-indications for anti-TNF-\u03b1 agents in cancer treatment.","volume":"34","author":"Grimm","year":"2011","journal-title":"Cell Oncol (Dordr)"},{"key":"R5-20251121","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1007\/s00262-023-03520-5","article-title":"PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies.","volume":"72","author":"Lin","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"R6-20251121","doi-asserted-by":"crossref","first-page":"10172","DOI":"10.3390\/ijms241210172","article-title":"The role of IL-23 in the pathogenesis and therapy of inflammatory bowel disease.","volume":"24","author":"Korta","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R7-20251121","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41419-019-2157-1","article-title":"NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-\u03baB signaling.","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis"},{"key":"R8-20251121","doi-asserted-by":"crossref","first-page":"100104","DOI":"10.1016\/j.jtauto.2021.100104","article-title":"Distinct roles of interleukin-17 and T helper 17 cells among autoimmune diseases.","volume":"4","author":"Akiyama","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"R9-20251121","doi-asserted-by":"crossref","first-page":"1370276","DOI":"10.3389\/fimmu.2024.1370276","article-title":"Interactions between circulating inflammatory factors and autism spectrum disorder: a bidirectional Mendelian randomization study in European population.","volume":"15","author":"Long","year":"2024","journal-title":"Front Immunol"},{"key":"R10-20251121","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41575-022-00663-1","article-title":"Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation.","volume":"20","author":"Zundler","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R11-20251121","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-021-03283-y","article-title":"MAP3K2-regulated intestinal stromal cells define a distinct stem cell niche.","volume":"592","author":"Wu","year":"2021","journal-title":"Nature"},{"key":"R12-20251121","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"R13-20251121","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","article-title":"Mendelian randomization for cardiovascular diseases: principles and applications.","volume":"44","author":"Larsson","year":"2023","journal-title":"Eur Heart J"},{"key":"R14-20251121","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data.","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R15-20251121","doi-asserted-by":"crossref","first-page":"4967641","DOI":"10.1155\/mi\/4967641","article-title":"Deciphering the interplay among inflammatory bowel disease, gut microbiota, and inflammatory biomarkers in the risk of colorectal cancer.","volume":"2025","author":"Luo","year":"2025","journal-title":"Mediators Inflamm"},{"key":"R16-20251121","doi-asserted-by":"crossref","first-page":"1432041","DOI":"10.3389\/fimmu.2024.1432041","article-title":"Causal association between circulating inflammatory proteins and peripheral artery disease: a bidirectional two-sample Mendelian randomization study.","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Immunol"},{"key":"R17-20251121","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal cancer in inflammatory bowel disease: mechanisms and management.","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology"},{"key":"R18-20251121","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R19-20251121","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R20-20251121","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s43587-021-00051-5","article-title":"Common genetic associations between age-related diseases.","volume":"1","author":"D\u00f6nerta\u015f","year":"2021","journal-title":"Nat Aging"},{"key":"R21-20251121","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41588-024-02044-7","article-title":"A scalable variational inference approach for increased mixed-model association power.","volume":"57","author":"Loya","year":"2025","journal-title":"Nat Genet"},{"key":"R22-20251121","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s41588-021-00954-4","article-title":"A generalized linear mixed model association tool for biobank-scale data.","volume":"53","author":"Jiang","year":"2021","journal-title":"Nat Genet"},{"key":"R23-20251121","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","article-title":"Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies.","volume":"50","author":"Zhou","year":"2018","journal-title":"Nat Genet"},{"key":"R24-20251121","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes.","volume":"491","author":"Abecasis","year":"2012","journal-title":"Nature"},{"key":"R25-20251121","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R26-20251121","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2021.04.042","article-title":"Genetic and epigenetic characteristics of inflammatory bowel disease-associated colorectal cancer.","volume":"161","author":"Rajam\u00e4ki","year":"2021","journal-title":"Gastroenterology"},{"key":"R27-20251121","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis.","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"key":"R28-20251121","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.3390\/ijms21207619","article-title":"CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 ligands.","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R29-20251121","doi-asserted-by":"crossref","first-page":"115858","DOI":"10.1016\/j.bcp.2023.115858","article-title":"Potential role of soluble CD40 receptor in chronic inflammatory diseases.","volume":"217","author":"Wagner","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"R30-20251121","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fimmu.2015.00529","article-title":"The contribution of CD40\/CD40L axis in inflammatory bowel disease: an update.","volume":"6","author":"Senhaji","year":"2015","journal-title":"Front Immunol"},{"key":"R31-20251121","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/gut.2006.111989","article-title":"Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease.","volume":"56","author":"Danese","year":"2007","journal-title":"Gut"},{"key":"R32-20251121","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00384-014-1936-5","article-title":"Experimental appendicitis and appendectomy modulate the CCL20-CCR6 axis to limit inflammatory colitis pathology.","volume":"29","author":"Cheluvappa","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"R33-20251121","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.3390\/ijms19103257","article-title":"C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in human peripheral blood mononuclear cells: dysregulated in ulcerative colitis and a potential role for CCL20 in IL-1\u03b2 Release.","volume":"19","author":"Skovdahl","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R34-20251121","first-page":"603","article-title":"CCL20 is negatively regulated by TGF-\u03b21 in intestinal epithelial cells and reduced in crohn\u2019s disease patients with a successful response to mongersen, a Smad7 antisense oligonucleotide.","volume":"11","author":"Marafini","year":"2017","journal-title":"J Crohns Colitis"},{"key":"R35-20251121","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2022.07.016","article-title":"SMAD4 suppresses colitis-associated carcinoma through inhibition of CCL20\/CCR6-mediated inflammation.","volume":"163","author":"Hanna","year":"2022","journal-title":"Gastroenterology"},{"key":"R36-20251121","doi-asserted-by":"crossref","first-page":"1357632","DOI":"10.3389\/fimmu.2024.1357632","article-title":"Identification and validation of hub genes expressed in ulcerative colitis with metabolic dysfunction-associated steatotic liver disease.","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"R37-20251121","first-page":"62","article-title":"Over-expression of immunosuppressive molecules, PD-L1 and PD-L2, in ulcerative colitis patients.","volume":"16","author":"Rajabian","year":"2019","journal-title":"Iran J Immunol"},{"key":"R38-20251121","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3904\/kjim.2024.019","article-title":"The role of PD-1\/PD-L1 pathway in ulcerative colitis and changes following tonsil-derived mesenchymal stem cells treatment.","volume":"39","author":"Song","year":"2024","journal-title":"Korean J Intern Med"},{"key":"R39-20251121","doi-asserted-by":"crossref","first-page":"e15481","DOI":"10.7717\/peerj.15481","article-title":"The significance of PD-1\/PD-L1 imbalance in ulcerative colitis.","volume":"11","author":"Shi","year":"2023","journal-title":"PeerJ"},{"key":"R40-20251121","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4251\/wjgo.v6.i5.129","article-title":"Modulators affecting the immune dialogue between human immune and colon cancer cells.","volume":"6","author":"Djaldetti","year":"2014","journal-title":"World J Gastrointest Oncol"},{"key":"R41-20251121","doi-asserted-by":"crossref","first-page":"917955","DOI":"10.3389\/fimmu.2022.917955","article-title":"Targeting IL-34\/MCSF-1R axis in colon cancer.","volume":"13","author":"Monteleone","year":"2022","journal-title":"Front Immunol"},{"key":"R42-20251121","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.2147\/CMAR.S253369","article-title":"Biochemical markers of colorectal cancer \u2013 present and future.","volume":"12","author":"Jelski","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R43-20251121","doi-asserted-by":"crossref","first-page":"115369","DOI":"10.1016\/j.fct.2025.115369","article-title":"Regulatory effect of curcumin on CD40:CD40L interaction and therapeutic implications.","volume":"200","author":"Askarizadeh","year":"2025","journal-title":"Food Chem Toxicol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:02:04Z","timestamp":1763766124000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":43,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045735","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"2025-07-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}